Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes

By E. Ferrannini, S. Baldi, S. Frascerra, B. Astiarraga, T. Heise, R. Bizzotto, A. Mari, T. Pieber, E. Muscelli. Diabetes, 2016

637 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/4d4ded7eed77107d8efb7519a007b0daf12a7e00

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. P. Crawford
2. Patrycja Puchalska

Citations in the corpus

• Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics (2017, background): “Inhibition of the renal proximal tubular sodium/glucose cotransporter 2 (SGLT2i) increases circulating ketone body concentrations in humans (Ferrannini et al., 2016a; Inagaki et al., 2015) and mice (Suzuki et al., 2014) via increased hepatic ketogenesis (Ferrannini et al., 2014, 2016a; Katz and…”